Purchase by BROADWOOD PARTNERS, L.P. / BROADWOOD CAPITAL INC / Neal C Bradsher
570,184 shares · @ $3.56 · $2,032,251
Insight Molecular Diagnostics Inc. Common Stock · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $6.16
+31% in 7d after detection
Post-detection moves
1h
—
1d
+9.4%
3d
+4.4%
7d
+31%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS